Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary fat binding refers to the molecular or pharmacological process of interacting with and sequestering dietary fats (primarily triglycerides and long-chain fatty acids) in the gastrointestinal tract, thereby reducing their absorption into the body. This mechanism is a target for weight management therapies and metabolic disease interventions, as it can decrease caloric intake from fats and modulate lipid metabolism. Fatty acid-binding proteins (FABPs) play a key role in lipid transport and metabolism. Exogenous compounds can also act as "fat binders".
Reversible sequestration/binding of dietary fats (triglycerides and fatty acids) in the gastrointestinal tract, reducing their absorption. Inhibition of FABP function.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary Fat Binding.